HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marshall Brinkley Selected Research

Anticoagulant Reversal Agents

9/2019Anticoagulation Reversal and Risk of Thromboembolic Events Among Heart Transplant Recipients Bridged with Durable Mechanical Circulatory Support Devices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marshall Brinkley Research Topics

Disease

2Primary Graft Dysfunction
11/2021 - 10/2021
1Heart Failure
11/2021
1Cardiogenic Shock
01/2021
1Thrombosis (Thrombus)
01/2021
1Hemorrhage
09/2019
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
10/2017

Drug/Important Bio-Agent (IBA)

1dicarboxydine (DCD)IBA
11/2021
1Prostaglandins DIBA
11/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021
1SolutionsIBA
01/2021
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2019
14-methyl-2,3-secocholestane-2,3-diolIBA
09/2019
1Prothrombin (Factor II)IBA
09/2019
1recombinant FVIIa (rFVIIa)FDA Link
09/2019
1Anticoagulant Reversal AgentsIBA
09/2019

Therapy/Procedure

4Heart Transplantation (Grafting, Heart)
11/2021 - 09/2019
1Renal Replacement Therapy (Therapies, Renal Replacement)
10/2017
1Extracorporeal Membrane Oxygenation
10/2017